Esteban Cynthia A, Klein Robert B, Kopel Sheryl J, McQuaid Elizabeth L, Fritz Gregory K, Seifer Ronald, York Daniel, Golova Natalie, Jandasek Barbara, Koinis-Mitchell Daphne
Division of Pediatric Allergy and Immunology, Warren Alpert Medical School of Brown University , Rhode Island Hospital, Providence, Rhode Island.
Division of Child and Adolescent Psychiatry, Warren Alpert Medical School of Brown University , Rhode Island Hospital, Providence, Rhode Island.
Pediatr Allergy Immunol Pulmonol. 2014 Jun 1;27(2):75-81. doi: 10.1089/ped.2014.0344.
Allergic rhinitis (AR) is a risk factor for the development of asthma, and if poorly controlled, it may exacerbate asthma. We sought to describe AR symptoms and treatment in a larger study about asthma, sleep, and school performance. We examined the proportion (1) who met criteria for AR in an urban sample of school children with persistent asthma symptoms, (2) whose caregivers stated that they were not told of their child's allergies, (3) who had AR but were not treated or were undertreated for the disease, as well as (4) caregivers and healthcare providers' perceptions of the child's allergy status compared with study assessment, and (5) associations between self-report of asthma and AR control over a 4-week monitoring period. One hundred sixty-six children with persistent asthma participated in a clinical evaluation of asthma and rhinitis, including allergy testing. Self-report of asthma control and rhinitis control using the Childhood Asthma Control Test (C-ACT) and Rhinitis Control Assessment Test (RCAT) were measured 1 month after the study clinic session. Persistent rhinitis symptoms were reported by 72% of participants; 54% of rhinitis symptoms were moderate in severity, though only 33% of the sample received adequate treatment. AR was newly diagnosed for 53% during the clinic evaluation. Only 15% reported using intranasal steroids. Participants with poorly controlled AR had poorer asthma control compared with those with well-controlled AR. This sample of urban school-aged children with persistent asthma had underdiagnosed and undertreated AR. Healthcare providers and caregivers in urban settings need additional education about the role of allergies in asthma, recognition of AR symptoms, and AR's essential function in the comanagement of asthma. Barriers to linkages with allergy specialists need to be identified.
变应性鼻炎(AR)是哮喘发生的一个危险因素,若控制不佳,可能会加重哮喘。我们试图在一项关于哮喘、睡眠和学业表现的更大规模研究中描述AR症状及治疗情况。我们调查了以下比例:(1)在有持续性哮喘症状的城市学龄儿童样本中符合AR标准的比例;(2)其照料者表示未被告知孩子过敏情况的比例;(3)患有AR但未接受治疗或治疗不足的比例;以及(4)与研究评估相比,照料者和医疗服务提供者对孩子过敏状态的认知情况;(5)在4周监测期内哮喘自我报告与AR控制之间的关联。166名患有持续性哮喘的儿童参与了哮喘和鼻炎的临床评估,包括过敏检测。在研究门诊就诊1个月后,使用儿童哮喘控制测试(C-ACT)和鼻炎控制评估测试(RCAT)对哮喘控制和鼻炎控制进行自我报告测量。72%的参与者报告有持续性鼻炎症状;54%的鼻炎症状为中度严重程度,但样本中只有33%接受了充分治疗。在临床评估期间,53%的患者被新诊断为AR。只有15%的人报告使用鼻内类固醇。与AR控制良好的参与者相比,AR控制不佳的参与者哮喘控制更差。这个患有持续性哮喘的城市学龄儿童样本中,AR的诊断不足且治疗不足。城市环境中的医疗服务提供者和照料者需要接受关于过敏在哮喘中的作用、AR症状的识别以及AR在哮喘联合管理中的重要作用的额外教育。需要确定与过敏专科医生联系的障碍。